Levels of Interleukin-6 andTransforming Growth Factor Beta in HCV Patients Sera
NCT03882307
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C, Chronic
Interventions
DRUG:
sofosbuvir and daclatasvir
Sponsor
Assiut University